Lupihope 10mg Tablet contains dydrogesterone, a synthetic progestogen structurally similar to natural progesterone, used primarily in the management of various gynecological conditions. Each tablet delivers 10mg of dydrogesterone, which acts by mimicking the effects of endogenous progesterone, thereby regulating the menstrual cycle and supporting pregnancy. Lupihope is indicated for the treatment of menstrual disorders such as irregular menstruation, secondary amenorrhea, and dysfunctional uterine bleeding. It is also employed in hormone replacement therapy to counteract estrogen-induced endometrial hyperplasia and as part of assisted reproductive technology protocols to support luteal phase insufficiency. Additionally, dydrogesterone is utilized in the prevention of threatened and recurrent miscarriage associated with progesterone deficiency. The drug exhibits a favorable safety profile with minimal androgenic or estrogenic side effects due to its selective progestogenic activity. Administration should follow medical guidance, with dosage tailored to the specific indication and patient response. Contraindications include known hypersensitivity to dydrogesterone or any excipients, active thrombophlebitis, or thromboembolic disorders. Monitoring during therapy is essential to evaluate efficacy and detect any adverse reactions. Lupihope 10mg Tablet offers a reliable therapeutic option for progesterone supplementation in various clinical scenarios.